FDA: Comment Period for Draft Guidance Extended to December 2nd
The industry breathed a temporary sigh of relief when they learned that FDA had extended the comment period for its New Dietary Ingredient (NDI) Draft
Follow us on :
The industry breathed a temporary sigh of relief when they learned that FDA had extended the comment period for its New Dietary Ingredient (NDI) Draft
Some insight and clarification offered from FDA but many questions left unanswered The Natural Products Association hosted a Webinar featuring both an audio and video
In a March 4th letter to Senator Chuck Grassley, the Ranking Member of the Committee on Finance, Commissioner Margaret Hamburg indicated that FDA plans to
The General Accountability Office (GAO) recently released a report to Congressional requesters on the issue of whether “FDA should take further actions to improve oversight
Fax: (516) 294-0477
Email: info@supplementcounsel.com
Address: 138 Mineola Blvd,
Mineola, NY 11501